3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
5
Neoplasm Metastasis
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Rectal Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hyperthermia
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Ovarian Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Metabolic Syndrome
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Interventions
Ketamine
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Tea
1
Quality of Life
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Oxycodone
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Hydromorphone
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Bupivacaine
1
Anti-Inflammatory Agents, Non-Steroidal
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Acute Pain
×
Diathermy
×
Clear all
NCT04778631
2025-11-20
PERISAFE
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
115 enrolled